Australia - English - Department of Health (Therapeutic Goods Administration)

taylor bio-medical pty ltd - ct827 - clinical chemistry enzyme ivds - enzyme colorimetry assays for the quantitative determination of clinical chemistry enzyme ivds.

Australia - English - Department of Health (Therapeutic Goods Administration)

taylor bio-medical pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

taylor bio-medical pty ltd - ct943 - instrument/analyser ivds - instrument/analyser ivds - manual , semi-automated/automated equipment/apparatus for processing , examining and/or providing information about a clinical specimen.

United States - English - NLM (National Library of Medicine)

taylor pharmaceuticals - droperidol (unii: o9u0f09d5x) (droperidol - unii:o9u0f09d5x) - injection - 2.5 mg in 1 ml - inapsine (droperidol) is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures. inapsine is contraindicated in patients with known or suspected qt prolongation (i.e., qtc interval greater than 440 msec for males or 450 msec for females). this would include patients with congenital long qt syndrome. inapsine (droperidol) is contraindicated in patients with known hypersensitivity to the drug. inapsine is not recommended for any use other than for the treatment of perioperative nausea and vomiting in patients for whom other treatments are ineffective or inappropriate (see warnings).

United States - English - NLM (National Library of Medicine)

taylor pharmaceuticals - dimercaprol (unii: 0cpp32s55x) (dimercaprol - unii:0cpp32s55x) - injection - 100 mg in 1 ml - bal in oil (dimercaprol injection usp) is indicated in the treatment of arsenic, gold and mercury poisoning. it is indicated in acute lead poisoning when used concomitantly with edetate calcium disodium injection usp. dimercaprol injection usp is effective for use in acute poisoning by mercury salts if therapy is begun within one or two hours following ingestion. it is not very effective for chronic mercury poisoning. dimercaprol injection usp is of questionable value in poisoning caused by other heavy metals such as antimony and bismuth. it should not be used in iron, cadmium, or selenium poisoning because the resulting dimercaprol-metal complexes are more toxic than the metal alone, especially to the kidneys. bal in oil (dimercaprol injection usp) is contraindicated in most instances of hepatic insufficiency with the exception of postarsenical jaundice. the drug should be discontinued or used only with extreme caution if acute renal insufficiency develops during therapy. dimercaprol injection usp is not a c

United States - English - NLM (National Library of Medicine)

taylor pharmaceuticals - alfentanil hydrochloride (unii: 11s92g0tiw) (alfentanil - unii:1n74hm2bs7) - injection - alfenta (alfentanil hydrochloride) is indicated: see dosage chart for more complete information on the use of alfenta. alfenta (alfentanil hydrochloride) is contraindicated in patients with known hypersensitivity to the drug or known intolerance to other opioid agonists. alfenta (alfentanil hydrochloride) is a schedule ii controlled drug substance that can produce drug dependence of the morphine type and therefore has the potential for being abused. opioid analgesics have been associated with abuse and dependence in health care providers and others with ready access to such drugs. alfenta should be handled accordingly.

United States - English - NLM (National Library of Medicine)

taylor pharmaceuticals - fentanyl citrate (unii: mun5lyg46h) (fentanyl - unii:uf599785jz) - injection, solution - sublimaze (fentanyl citrate) is indicated: sublimaze (fentanyl citrate) is contraindicated in patients with known intolerance to the drug or other opioid agonists. sublimaze (fentanyl citrate) is a schedule ii controlled drug substance that can produce drug dependence of the morphine type and therefore has the potential for being abused.

United States - English - NLM (National Library of Medicine)

taylor pharmaceuticals - sufentanil citrate (unii: s9zfx8403r) (sufentanil - unii:afe2yw0iiz) - solution - sufenta (sufentanil citrate) is indicated for intravenous administration in adults and pediatric patients: as an analgesic adjunct in the maintenance of balanced general anesthesia in patients who are intubated and ventilated. as a primary anesthetic agent for the induction and maintenance of anesthesia with 100% oxygen in patients undergoing major surgical procedures, in patients who are intubated and ventilated, such as cardiovascular surgery or neurosurgical procedures in the sitting position, to provide favorable myocardial and cerebral oxygen balance or when extended postoperative ventilation is anticipated. sufenta (sufentanil citrate) is indicated for epidural administration as an analgesic combined with low dose bupivacaine, usually 12.5 mg per administration, during labor and vaginal delivery. see dosage and administration section for more complete information on the use of sufenta. sufenta is contraindicated in patients with known hypersensitivity to the drug or known intolerance to other opioid ago

Australia - English - Department of Health (Therapeutic Goods Administration)

taylor bio-medical pty ltd - ct850 - clinical chemistry hormone ivds - immunochromatographic assays for the semi-quantitative determination of clinical chemistry hormone ivds.

United States - English - NLM (National Library of Medicine)

taylor drug operating services dba taylor drug - oxygen (unii: s88tt14065) (oxygen - unii:s88tt14065) -